Clinical Nurse Specialist in Ravenna, OH Accepting Medicare

6 Clinical Nurse Specialist nurses found. Showing 1 - 6

Mary Elizabeth Penkala, CNS Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 6847 N Chestnut St Ste 115, Ravenna, OH 44266 Phone: 330-297-6055

Dr. Winola S. Sprague, CNS Clinical Nurse Specialist - Psych/Mental Health, Child & Family Medicare: Not Enrolled in Medicare Practice Location: 520 N Chestnut St, Ravenna, OH 44266 Phone: 330-296-5552    Fax: 330-296-1310

Janet Bahle, CNS Clinical Nurse Specialist - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6847 N Chestnut St, Ravenna, OH 44266 Phone: 330-297-0811

Cynthia Ann Majercik, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6847 N Chestnut St, Ravenna, OH 44266 Phone: 330-297-0811

Lana F Schuette, CNS Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 6847 N. Chestnut Street, Medical Staff Office, Ravenna, OH 44266 Phone: 330-297-2461    Fax: 330-297-8463

Edward Eichler, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6847 N Chestnut St, Ravenna, OH 44266 Phone: 330-297-0811

News Archive

Paxil and Pravachol in combination cause unexpected increase in blood glucose levels

A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a study conducted at the Stanford University School of Medicine, Vanderbilt University and Harvard Medical School. Researchers were surprised at the finding because neither of the two drugs - one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol - has a similar effect alone.

Scientists uncover mechanism that prevents tumor growth in melanoma

Natural Killer (NK) cells, lymphocytes of the innate immune system with strong cytotoxic activity, play a major role in the immune response against tumors.

ORBERA Managed Weight Loss System receives final approval from FDA

The ORBERA™ Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.

BIO commends GSK and Alnylam's efforts to foster new therapies for neglected diseases

The Biotechnology Industry Organization (BIO) applauds the joint efforts of BIO members GlaxoSmithKline and Alnylam Pharmaceuticals to encourage research to accelerate medical therapies for neglected diseases and today's announcement of the selection of BIO Ventures for Global Health (BVGH) as the administrator of the Intellectual Property (IP) Pool.

Reid: Lawmakers may not complete health legislation this year

CongressDaily: "Senate Majority Leader Reid is not expected to receive until next week scoring from CBO that will allow him to piece together a final healthcare overhaul bill, Senate sources said today. The possible two-week review period on proposals that Reid sent CBO Oct. 26 has bolstered speculation that an overhaul bill might not come to the Senate floor before December in a debate that could stretch into next year."

Read more Medical News

› Verified 5 days ago